Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis

J Gen Virol. 2000 Feb;81(Pt 2):317-25. doi: 10.1099/0022-1317-81-2-317.

Abstract

This study aimed to assess the role of specific human papillomavirus type 16 (HPV-16) variants, in combination with p53 codon 72 polymorphism genotypes, in cervical carcinogenesis. An initial sequence analysis of HPV-16 long control, E6 and E7 regions of 53 well-defined cervical samples containing HPV-16 revealed that a T to G transition at nucleotide position 350 within the E6 open reading frame was the most common variation, the frequency of which seemed to decrease with increasing severity of the lesion. Therefore, a total of 246 cervical samples of residents of The Netherlands was specifically analysed for HPV-16 350G/T variants and/or p53 codon 72 genotypes. These comprised HPV-negative normal cervical scrapes (n=40), normal cervical scrapes containing HPV-16 (n=46), scrapes containing HPV-16 from women with abnormal cervical cytology participating in a non-intervention follow-up study without (n=38) and with (n=51) a histologically proven cervical intraepithelial neoplasia (CIN) III lesion at the end of the study, and cervical squamous cell carcinomas (n=71). Neither specific HPV-16 350G/T variants nor specific p53 genotypes were associated with a higher risk of developing CIN III or cervical cancer. However, HPV-16 350T variants were significantly over-represented in p53 Arg homozygous women with cervical cancer. This suggests that, in p53 Arg/Arg women, infection with HPV-16 350T variants confers a higher risk of cervical cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Carcinoma, Squamous Cell / chemically induced
  • Carcinoma, Squamous Cell / etiology
  • Carcinoma, Squamous Cell / genetics
  • Codon / genetics
  • DNA Primers / genetics
  • DNA, Viral / genetics
  • Female
  • Genes, p53*
  • Genetic Variation
  • Genotype
  • Humans
  • Molecular Sequence Data
  • Oncogene Proteins, Viral / genetics
  • Papillomaviridae / genetics*
  • Papillomaviridae / pathogenicity*
  • Papillomavirus E7 Proteins
  • Papillomavirus Infections / complications
  • Papillomavirus Infections / genetics
  • Papillomavirus Infections / virology
  • Polymorphism, Genetic
  • Repressor Proteins*
  • Risk Factors
  • Sequence Homology, Nucleic Acid
  • Tumor Virus Infections / genetics
  • Tumor Virus Infections / virology
  • Uterine Cervical Dysplasia / etiology
  • Uterine Cervical Dysplasia / genetics*
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / etiology
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / virology*

Substances

  • Codon
  • DNA Primers
  • DNA, Viral
  • E6 protein, Human papillomavirus type 16
  • Oncogene Proteins, Viral
  • Papillomavirus E7 Proteins
  • Repressor Proteins
  • oncogene protein E7, Human papillomavirus type 16

Associated data

  • GENBANK/AJ242681
  • GENBANK/AJ388056
  • GENBANK/AJ388057
  • GENBANK/AJ388058
  • GENBANK/AJ388059
  • GENBANK/AJ388060
  • GENBANK/AJ388061
  • GENBANK/AJ388062
  • GENBANK/AJ388063
  • GENBANK/AJ388064
  • GENBANK/AJ388065
  • GENBANK/AJ388066
  • GENBANK/AJ388067
  • GENBANK/AJ388068
  • GENBANK/AJ388069